9th January 2023

Hull Trials Unit (University of Hull), in collaboration with Hull University Teaching Hospitals NHS Trust and Hull York Medical School, are calling for health care providers to complete a short survey about corticosteroids in bacterial septic arthritis, which aims to improve patient outcomes for this debilitating condition, but could also influence antimicrobial prescribing.

Septic arthritis is an acute bacterial infection of one or more native joints. Clinical outcomes are poor with about 40-50% suffering long-term sequelae. Pro-inflammatory cytokine levels in the joint correlate negatively with patients’ quality of life and the level of osteoarthritis at 1-year.

Current clinical management addresses the underlying causal pathology (surgical and antibiotic treatment of the infection), but not the associated joint inflammation. There is some evidence supporting the use of corticosteroids for children with septic arthritis, but most cases in the UK occur in adults. A recent journal article suggested doctors treating septic arthritis should consider using corticosteroids, even without the required research evidence-base.

We propose research to investigate the addition of systemic corticosteroids (intravenous or oral) to existing UK standard of care (joint drainage and at least 4 weeks of antibiotics) in acute bacterial native, large-joint septic arthritis and would be very interested, and grateful, for your answers to the questions below (it will take about 5 minutes or less):

Take the survey now

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member

Having trouble finding what you're after?